Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy - PubMed (original) (raw)
Multicenter Study
. 2008 Feb 15;197(4):563-71.
doi: 10.1086/526786.
Marylyn M Addo, Daniel E Kaufmann, Yang Liu, Toshiyuki Miura, Almas Rathod, Brett Baker, Alicja Trocha, Rachel Rosenberg, Elizabeth Mackey, Peggy Ueda, Zhigang Lu, Daniel Cohen, Terri Wrin, Christos J Petropoulos, Eric S Rosenberg, Bruce D Walker
Affiliations
- PMID: 18275276
- DOI: 10.1086/526786
Multicenter Study
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra et al. J Infect Dis. 2008.
Abstract
Background: Spontaneous control of human immunodeficiency virus (HIV) infection has been documented in a minority of HIV-infected individuals. The mechanisms behind this outcome remain largely unknown, and a better understanding of them will likely influence future vaccine strategies.
Methods: HIV-specific T cell and antibody responses as well as host genetics were examined in untreated HIV-infected patients who maintain comparatively low plasma HIV RNA levels (hereafter, controllers), including those with levels of < 50 RNA copies/mL (elite controllers, n = 64), those with levels of 50-2000 copies/mL (viremic controllers, n = 60); we also examined HIV-specific T cell and antibody responses as well as host genetics for patients with levels of >10,000 copies/mL (chronic progressors, n = 30).
Results: CD8+ T cells from both controller groups preferentially target Gag over other proteins in the context of diverse HLA class I alleles, whereas responses are more broadly distributed in persons with progressive infection. Elite controllers represent a distinct group of individuals who have significantly more CD4 and CD8 T cells that secrete interferon-gamma and interleukin-2 and lower levels of HIV-neutralizing antibodies. Individual responses were quite heterogeneous, and none of the parameters evaluated was uniquely associated with the ability to control viremia.
Conclusions: Elite controllers are a distinct group, even when compared to persons with low level viremia, but they exhibit marked genetic and immunologic heterogeneity. Even low-level viremia among HIV controllers was associated with measurable T cell dysfunction, which has implications for current prophylactic vaccine strategies.
Similar articles
- HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. Emu B, et al. J Virol. 2008 Jun;82(11):5398-407. doi: 10.1128/JVI.02176-07. Epub 2008 Mar 19. J Virol. 2008. PMID: 18353945 Free PMC article. - Impaired Nef function is associated with early control of HIV-1 viremia.
Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA. Kuang XT, et al. J Virol. 2014 Sep 1;88(17):10200-13. doi: 10.1128/JVI.01334-14. Epub 2014 Jun 25. J Virol. 2014. PMID: 24965469 Free PMC article. - CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, Ismail N, Mncube Z, Mkhize L, van der Stok M, Yende N, Walker BD, Goulder PJR, Ndung'u T. Koofhethile CK, et al. J Virol. 2016 Jul 11;90(15):6818-6831. doi: 10.1128/JVI.00276-16. Print 2016 Aug 1. J Virol. 2016. PMID: 27194762 Free PMC article. - HIV-specific CD4 T cells and immune control of viral replication.
Porichis F, Kaufmann DE. Porichis F, et al. Curr Opin HIV AIDS. 2011 May;6(3):174-80. doi: 10.1097/COH.0b013e3283454058. Curr Opin HIV AIDS. 2011. PMID: 21502921 Free PMC article. Review. - Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?
Blankson JN. Blankson JN. Antiviral Res. 2010 Jan;85(1):295-302. doi: 10.1016/j.antiviral.2009.08.007. Epub 2009 Sep 4. Antiviral Res. 2010. PMID: 19733595 Free PMC article. Review.
Cited by
- Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection.
Jennewein MF, Mabuka J, Papia CL, Boudreau CM, Dong KL, Ackerman ME, Ndung'u T, Alter G. Jennewein MF, et al. Front Immunol. 2020 Aug 7;11:1744. doi: 10.3389/fimmu.2020.01744. eCollection 2020. Front Immunol. 2020. PMID: 32849622 Free PMC article. - Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ. Tomescu C, et al. AIDS. 2012 Sep 24;26(15):1869-78. doi: 10.1097/QAD.0b013e32835861b0. AIDS. 2012. PMID: 22874514 Free PMC article. - CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
Lécuroux C, Girault I, Chéret A, Versmisse P, Nembot G, Meyer L, Rouzioux C, Pancino G, Venet A, Sáez-Cirión A; ANRS 147 OPTIPRIM clinical trial. Lécuroux C, et al. PLoS One. 2013;8(3):e59767. doi: 10.1371/journal.pone.0059767. Epub 2013 Mar 29. PLoS One. 2013. PMID: 23555774 Free PMC article. Clinical Trial. - SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps.
Sertznig H, Roesmann F, Wilhelm A, Heininger D, Bleekmann B, Elsner C, Santiago M, Schuhenn J, Karakoese Z, Benatzy Y, Snodgrass R, Esser S, Sutter K, Dittmer U, Widera M. Sertznig H, et al. Front Immunol. 2022 Nov 15;13:935800. doi: 10.3389/fimmu.2022.935800. eCollection 2022. Front Immunol. 2022. PMID: 36458014 Free PMC article. - Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.
Wikramaratna PS, Lourenço J, Klenerman P, Pybus OG, Gupta S. Wikramaratna PS, et al. Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):20140290. doi: 10.1098/rstb.2014.0290. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 26150656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials